Product Name | MF | CAS | Details |
---|
Fosfomycin Trometamol EP Impurity A (1,2-dihydroxypropyl)phosphonic acid | C3H9O5P | 84954-80-3 | Details |
ROSUVASTATIN IMPURITY-K | C22H26FN3O5S | 1422954-12-8 | Details |
LURASIDONE DP5- IMPURITY Lurasidone Sulfone | C28H36N4O4S | 1644295-09-9 | Details |
Paracetamol EP Impurity J N-(4-chlorophenyl)acetamide | C8H8ClNO | 539-03-7 | Details |
Atenolol EP Impurity B 2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide | C11H15NO4 | 61698-76-8 | Details |
Pantoprazole Chloro Impurity 2-(chloromethyl)-3,4-dimethoxypyridine hydrochloride | C8H11Cl2NO2 | 72830-09-2 | Details |
Brexpiprazole Impurity 3 5-Hydroxy-2(1H)-quinolinone | C9H7NO2 | 31570-97-5 | Details |
Desloratadine Desloratadine ; Loratadine USP RC A ; Loratadine EP Impurity D | C19H19ClN2 | 100643-71-8 | Details |
Phenoxymethylpenicillin EP Impurity B Glycolic acid phenyl ether ; 2-phenoxyacetic acid | C8H8O3 | 122-59-8 | Details |
Levodopa EP Impurity A Levodopa USP Related Compound A ; (2S)-2-Amino-3-(2,4,5- trihydroxyphenyl)propanoic acid | C9H11NO5 | 27244-64-0 | Details |
Nifedipine EP impurity A Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5- dicarboxylate (nitrophenylpyridine analogue) | C17H16N2O6 | 67035-22-7 | Details |
Bumetanide EP Impurity A Bumetanide Related Compound B ; 3-nitro-4-phenoxy-5- sulfamoylbenzoic acid | C13H10N2O7S | 28328-53-2 | Details |
Prasugrel EP Impurity I 1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one | C11H11FO | 150322-73-9 | Details |
Gliclazide 1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4- methylphenyl)sulfonyl]urea | C15H21N3O3S | 21187-98-4 | Details |
Pirfenidone EP Impurity B 5-methylpyridin-2(1H)-one | C6H7NO | 1003-68-5 | Details |
Atenolol EP Impurity J 2-(4-(3-amino-2-hydroxypropoxy)phenyl)acetamide | C11H16N2O3 | 81346-71-6 | Details |
Mesalazine EP Impurity N 2-hydroxy-5-nitrobenzoic acid (5-nitrosalicylic acid). ; Mesalamine EP Impurity N | C7H5NO5 | 96-97-9 | Details |
Metronidazole EP impurity G 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetic acid | C6H7N3O4 | 1010-93-1 | Details |
Pregabalin Impurity 4/Pregabalin Impurity B (3-Isobutylglutaric Acid) ; 3-isobutylpentanedioic acid | C9H16O4 | 75143-89-4 | Details |
Esomeprazole EP Impurity C Omeprazole EP Impurity C ; 5-methoxy-2-[[(4-methoxy-3,5- dimethylpyridin-2-yl)methyl]sulfanyl]-1H-benzimidazole (ufiprazole) | C17H19N3O2S | 73590-85-9 | Details |
Pioglitazone M1 Metabolite 5-(4-Hydroxybenzyl)-1,3-thiazolidine-2,4-dione | C10H9NO3S | 74772-78-4 | Details |
Telmisartan Methyl Ester 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl) -2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid methyl ester | C34H32N4O2 | 528560-93-2 | Details |
Apixaban 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]- 4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C25H25N5O4 | 503612-47-3 | Details |
Alfuzosin EP Impurity F 6,7-dimethoxy-N2,N2-dimethylquinazoline-2,4-diamine ; 4- Amino-2-(dimethylamino)-6,7-dimethoxy-quinazoline | C12H16N4O2 | 19216-53-6 | Details |
Memantine Related Compound A (1r,3r,5s,7s)-1,3-dimethyladamantane | C12H20 | 702-79-4 | Details |
Brexpiprazole Impurity 5 7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) | C22H20N2O4 | 2116542-19-7 | Details |
Progesterone EP Impurity B | C21H32O2 | 145-14-2 | Details |
Aspartame (S)-3-Amino-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2- yl)amino)-4-oxobutanoic acid | C14H18N2O5 | 22839-47-0 | Details |
Lurasidone DP4- IMPURITY Lurasidone Sulfoxide | C28H36N4O3S | 1809325-45-8 | Details |
Pirfenidone EP Impurity C phenol | C6H6O | 108-95-2 | Details |
Olmesartan Medoxomil Impurity 5 (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Chloride; 4- Chloromethyl-5-methyl-2-oxo-1,3-dioxole | C5H5ClO3 | 80841-78-7 | Details |
Hydroxychloroquine Sulfate 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol Sulfate | C18H28ClN3O5S | 747-36-4 | Details |
Cetirizine EP Impurity G Cetirizine Ethanol Impurity ; (R)-2-(4-((4- hlorophenyl)(phenyl)methyl)piperazin-1-yl)ethan-1-ol Dihydrochloride | C19H25Cl3N2O | 164726-80-1 | Details |
Irbesartan 2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3- diazaspiro[4.4]non-1-en-4-one | C25H28N6O | 138402-11-6 | Details |
Loratadine EP Impurity B Loratadine USP Related Compound C ; 8-Chloro-5,6-dihydro- 11H-benzo[5.6] cyclohepta[1,2-b]pyridin-11-one | C14H10ClNO | 31251-41-9 | Details |
Nitroso-N-methyl-4-aminobutyric acid (NMBA) 4-(Methylnitrosoamino)butanoic Acid; N-Methyl-N-(3- carboxypropyl)nitrosamine | C5H10N2O3 | 61445-55-4 | Details |
Dextromethorphan Impurity A (+)-3-Methoxy morphinan; (4bR,8aR,9R)-3-Methoxy- 6,7,8,8a,9,10-hexahydro-5H-9,4b- (epiminoethano)phenanthrene | C17H23NO | 1531-25-5 | Details |
Chlordiazepoxide EP Impurity A Chlordiazepoxide Related Compound A (7-Chloro-1,3-dihydro-5- phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) | C15H11ClN2O2 | 963-39-3 | Details |
Diclofenac EP Impurity A Diclofenac USP Related Compound A;Aceclofenac EP Impurity I ; Diclofenac Amide | C14H9Cl2NO | 15362-40-0 | Details |
Clonidine EP Impurity B Clonidine Related Compound A ; 1-(2-((2,6- dichlorophenyl)amino)-4,5-dihydro-1H-imidazol-1-yl)ethan-1- one | C11H11Cl2N3O | 54707-71-0 | Details |
Dabigatran Impurity 10 Dabigatran Etexilate Propanoate | C35H43N7O5 | 1304574-20-6 | Details |
Ranolazine Related Compound C 1-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine | C14H21N3O | 5294-61-1 | Details |
Ondansetron Hydrocloride 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9- tetrahydro-4H-carbazol-4-one hydrochloride dihydrate | C18H22ClN3O2 | 103639-04-9 | Details |
Metolazone 7- Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6 quinazolinesulfonamide | C16H16ClN3O3S | 17560-51-9 | Details |
Febuxostat 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5- carboxylic acid | C16H16N2O3S | 144060-53-7 | Details |
Lacosamide EP Impurity J Phenylmethanamine | C7H9N | 100-46-9 | Details |
Teriflunomide ortho isomer | Details |
Bupivacaine EP Impurity A N-(2,6-Dimethylphenyl)pyridine-2-carboxamide | C14H14N2O | 39627-98-0 | Details |
Azilsartan Impurity 1 methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl) -2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | C25H21N3O3 | 139481-44-0 | Details |
Dabigatran Impurity 2 N-(4-Cyanophenyl)glycine ; 2-(4-Cyanophenylamino)acetic acid | C9H8N2O2 | 42288-26-6 | Details |
Chlortalidone Impurity J 3-(4-chlorophenyl)-3-hydroxyisoindolin-1-one | C14H10ClNO2 | 956-92-3 | Details |
Metoprolol Succinate Bis[(2RS)-1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)- amino]propan-2-ol] butanedioate | 2C15H25NO3.C4H6O4 | 98418-47-4 | Details |
Brimonidine EP Impurity C Quinoxalin-6-amine | C8H7N3 | 6298-37-9 | Details |
Atenolol 2-[4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl]acetamide | C14H22N2O3 | 29122-68-7 | Details |
Fenticonazole Nitrate EP Impurity A 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethan-1-ol | C11H10Cl2N2O | 24155-42-8 | Details |
Brexpiprazole Impurity 13 4-Bromo benzo[b]thiophene | C8H5BrS | 5118-13-8 | Details |
Pregabalin Impurity 5 3-(2-amino-2-oxoethyl)-5-methylhexanoic acid | C9H17NO3 | 181289-15-6 | Details |
Quetiapine EP Impurity B Quetiapine USP Related Compound B ; Dibenzo[b,f][1,4]thiazepine-11-yl-piperazine dihydrochloride | C17H18ClN3S | 111974-74-4 | Details |
Lenalidomide 3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6- piperidinedione | C13H13N3O3 | 191732-72-6 | Details |
Bumetanide EP Impurity C butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate | C21H28N2O5S | 32643-00-8 | Details |
Bupivacaine HCl (2RS)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride | C18H28N2O.ClH | 18010-40-7 | Details |
4-phenyl thio benzyl chloride (4-(chloromethyl)phenyl)(phenyl)sulfane | C13H11ClS | 1208-87-3 | Details |
Metolazone EP Impurity E Metolazone USP RC B ; Metolazone benzamide analog ; | C14H14ClN3O3S | 23380-54-3 | Details |
Lacosamide (2R)-2-(Acetylamino)-3-methoxy-N- (phenylmethyl)propanamide | C13H18N2O3 | 175481-36-4 | Details |
Venlafaxine EP Impurity D Venlafaxine USP Related Compound A | C16H25NO2 | 149289-30-5 | Details |
Pioglitazone N-Oxide 5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy]phenyl]methyl]-2,4- thiazolidinedione N-oxide | C19H20N2O4S | 145350-09-0 | Details |
Aspartame EP Impurity C Phenylalanine | C9H11NO2 | 150-30-1 | Details |
3-Methylacetophenone | C9H10O | 585-74-0 | Details |
Irbesartan Impurity C 2-[4-(Hydroxymethyl)phenyl]benzonitrile; 4-(Hydroxymethyl)-2'- cyanobiphenyl | C14H11NO | 154709-19-0 | Details |
Ranolazine Related Compound 4 1-(2-methoxyphenoxy)-2,3- epoxy propane | C10H12O3 | 2210-74-4 | Details |
Celecoxib Related Compound 4 4,4,4-trifluoro-1-p-tolylbutane-1,3-dione | C11H9F3O2 | 720-94-5 | Details |
Olmesartan Imidazole Ethyl Ester Impurity Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5- carboxylate | C12H20N2O3 | 144689-93-0 | Details |
Venlafaxine EP Impurity E (5RS)-5-(4-methoxyphenyl)-3-methyl-1-oxa-3- azaspiro[5.5]undecane | C17H25NO2 | 93413-70-8 | Details |
Donepezil Benzyl Bromide 1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl) methyl]piperidinium bromide | C31H36BrNO3 | 844694-85-5 | Details |
2-Phenyl-1,3-propanediol | C9H12O2 | 1570-95-2 | Details |
Celecoxib Impurity 7 4,4,4-trifluoro-1-(o-tolyl)butane-1,3-dione | C11H9F3O2 | 163266-02-2 | Details |
Losartan EP Impurity D Losartan USP RC A ; 2-Butyl-4-chloro-1H-imidazole-5- carbaldehyde | C8H11ClN2O | 83857-96-9 | Details |
Metoprolol EP Impurity A Metoprolol USP Related Compound A | C14H23NO3 | 109632-08-8 | Details |
Metoprolol USP Related Compound B (+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]- propane | C12H17ClO3 | 56718-76-4 | Details |
Methyltestosterone 17-Hydroxy-17-methyl-3-keto-androstene-4 | C20H30O2 | 58-18-4 | Details |
Progesterone | C21H30O2 | 57-83-0 | Details |
Atorvastatin calcium salt Calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3- phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]- 3,5dihydroxyheptanoate | C33H35FN2O5 | 134523-00-5 | Details |
Fexofenadine EP Impurity A Fexofenadine USP related compound A | C32H37NO4 | 76811-98-8 | Details |
Lansoprazole Sulfone N-Oxide 2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2- pyridinyl]methyl]sulfonyl]-1H-benzimidazole | C16H14F3N3O4S | 953787-54-7 | Details |
Leflunomide EP Impurity C Leflunomide USP RC C ; 5-methyl-N-(3- (trifluoromethyl)phenyl)isoxazole-4-carboxamide | C12H9F3N2O2 | 61643-23-0 | Details |
Prucalopride Succinate 4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3 -dihydrobenzofuran-7-carboxamide succinate | C22H32ClN3O7 | 179474-85-2 | Details |
Valsartan EP Impurity C Valsartan related compound B ; Valsartan N-Butyryl Analog | C23H27N5O3 | 952652-79-8 | Details |
Aripiprazole Impurity 6 7-Hydroxyquinoline-(1H)-2-one , 7-Hydroxy-2(1H)-quinolinone | C10H12Cl2N2 | 63386-61-8 | Details |
Felbamate Related Compound B phenethyl carbamate | C9H11NO2 | 6326-19-8 | Details |
Irbesartan Cyano Impurity 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3- yl)methyl]biphenyl-2-carbonitrile | C25H27N3O | 138401-24-8 | Details |
Celecoxib Impurity 5 (E)-4-(2-(1-p-tolylethylidene)hydrazinyl)benzenesulfonamide | C15H17N3O2S | 1061214-06-9 | Details |
Desloratadine N-Formyl Impurity Desloratadine USP RC F; Desloratadine N-Formyl Impurity | C20H19ClN2O | 117810-61-4 | Details |
Olmesartan Impurity 6 ethyl 4-acetyl-2-propyl-1H-imidazole-5-carboxylate | C11H16N2O3 | 144690-07-3 | Details |
Prasugrel EP Impurity G Prasugrel Diketone ; 1-cyclopropyl-2-(2-fluorophenyl)ethane- 1,2-dione | C11H9FO2 | 1391054-37-7 | Details |
Telmisartan 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl- 1H-1,3 -benzodiazol-1-yl] methyl}phenyl)benzoic acid | C33H30N4O2 | 144701-48-4 | Details |
Olmesartan EP Impurity D N2-Trityl Olmesartan Medoxomil | C48H44N6O6 | 1020157-01-0 | Details |
Cetirizine EP Impurity Ethyl Ester (RS)-2-[4-[(4-Chlorophenyl)phenylmethyl] piperazin-1-yl]acetic acid ethyl ester | C21H25ClN2O2 | 19178-83-7 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 |